Across clinics, metformin was prescribed (63%) to a majority of overweight or obese patients; 57% of patients with hypertension were prescribed ACE inhibitors; 43% of patients with risk factors for cardiovascular events received prophylactic acetylsalicylic acid; and 48% of those with hypercholesterolemia received a statin. The gene discussed is ACE; the disease is Hypercholesterolemia.